Riskpilot← Back to searchSign inGet full accessAB Per och Eva Barnmedicin
ABIn liquidationOrg 5567697296Medical specialists activities · NACE 8622Est. 20080 employees
Revenue 2025
—
EBITDA margin
—
+16% vs 2024
Equity ratio
99.7%
Financial strength
Net profit 2025
SEK 3,3M
+1772% vs 2024
| Revenue | — | — |
| EBITDA | SEK -174K | +16% |
| Net profit | SEK 3,3M | +1772% |
| Total assets | SEK 7,8M | +74% |
| Equity | SEK 7,7M | +74% |
| Employees | 0 | — |
Legal name
AB Per och Eva Barnmedicin
Org number
5567697296
Legal form
Aktiebolag
NACE code
8622 · Medical specialists activities
Founded
13 november 2008
Share capital
SEK 100 000
Employees
0
VAT registered
No
Audit selected
No
Last report
2025-04-30
Financial year
January – December
Signatory rights
Firman tecknas ensam av likvidatorn
Company purpose
Bolaget ska bedriva verksamhet inom hälso- och sjukvård och därmed förenlig verksamhet.
Address
Email
bo@sundaffarsbyra.se
Risika for professionals
Risika provides regulated workflow tools for finance, procurement and compliance teams that need monitoring, alerts and an API.
| Item | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|
| Revenue | 0 | 0 | 0 | 4 | — |
| Staff expenses | — | −18 | −11 | −14 | −20 |
| EBITDA | −89 | −123 | −134 | −208 | −174 |
| Depreciation & amort. | −0 | — | — | — | — |
| EBIT | −89 | −123 | −134 | −208 | −174 |
| Net financials | 5 | −4 | 6 | 11 | 3 461 |
| Profit before tax | −32 | −41 | −118 | −197 | 3 287 |
| Tax | −0 | −0 | — | — | — |
| Net profit | −32 | −41 | −118 | −197 | 3 287 |
| Item | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|
| Total assets | 5 662 | 5 354 | 4 796 | 4 469 | 7 756 |
| Equity | 5 545 | 5 324 | 5 026 | 4 449 | 7 736 |
| Long-term debt | 0 | — | — | — | — |
| Short-term debt | 20 | 21 | −230 | 20 | 20 |
| Total debt | 20 | 21 | −230 | 20 | 20 |
EBITDA margin
-17367700.0%
This company
15.8%
Market median
-109922252% vs market
20212025
Equity ratio
99.7%
This company
38.2%
Market median
+161% vs market
20212025
Return on equity
42.5%
This company
18.4%
Market median
+131% vs market
20212025
Net profit margin
328731300.0%
This company
8.1%
Market median
+4058411011% vs market
20212025
Asset turnover
0.00×
This company
1.12×
Market median
-100% vs market
20212025
Debt / equity
0.00×
This company
0.62×
Market median
+100% vs market
20212025
- Annual report 2025Filed via Bolagsverket / SCB · Period 2024-05-01 – 2025-04-30
- Annual report 2024Filed via Bolagsverket / SCB · Period 2023-05-01 – 2024-04-30
- Annual report 2023Filed via Bolagsverket / SCB · Period 2022-05-01 – 2023-04-30
- Annual report 2022Filed via Bolagsverket / SCB · Period 2021-05-01 – 2022-04-30
- Annual report 2021Filed via Bolagsverket / SCB · Period 2020-05-01 – 2021-04-30
| Name | Role | Member since |
|---|---|---|
| Current (1) | ||
LP Liquidator | Liquidator | 2025 |
| Name | Role | Member since |
|---|---|---|
| Former (2) | ||
| Deputy Board Member | 2022 – 2025 | |
| Board of Directors | 2022 – 2025 | |
No shareholder data available.
Beneficial ownership (UBO) data access is restricted in Denmark as of September 2025 per the EU 6th AML Directive. Learn more.
No registered parent or subsidiaries
Board members of AB Per och Eva Barnmedicin also hold positions in 0 other companies.
| Person | Role here | Other companies |
|---|---|---|
| Lars Peter Rangemo | Liquidator | 0 companies |
| Eva Ingrid K Blomqvist Håkansson | Deputy Board Member | 0 companies |
| Per Håkan Håkansson | Board of Directors | 0 companies |